Andrew Sparks joined Omnione in 2019 as the SVP of Research & Development. Andrew brings experience developing, launching, and sustaining products leveraging diverse molecular technologies, including sample prep, microarray and NGS, for both research and clinical diagnostics applications. Andrew has built and lead high-performance teams encompassing research, development, operations, manufacturing, quality, regulatory, and customer/field support functions.
Prior to Omnione, Andrew held positions at Roche, Ariosa Diagnostics, Complete Genomics, Affymetrix, Perlegen Sciences, GMP Genetics and BioCeryx.
Andrew received his PhD in Molecular Genetics from the University of North Carolina at Chapel Hill and completed a post-doctoral fellowship in Cancer Genetics at the Johns Hopkins University School of Medicine.